P. Lagrange

L. Abel, P. Lagrange, N. Thuc, 1994, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Review: Bacterial endotoxin and the human monoclonal antibody HA-IA: specificity, potential mechanisms of action, and limits to its effectiveness

P. Lagrange, A. Felten, H. Blanchard, 1995 .

Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.

P. Lagrange, A. Philippon, G. Arlet, 1998, FEMS microbiology letters.

Different time course patterns of local expression of delayed-type hypersensitivity to sheep red blood cells in mice.

P. Lagrange, M. Maire, M. Hurtrel, 1992, Cellular immunology.

Prevalence of and risk factors for Clostridium difficile colonization at admission to an infectious diseases ward.

Y. Hutin, P. Lagrange, I. Casin, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine.

P. Lagrange, M. Gheorghiu, C. Fillastre, 1988, Journal of biological standardization.

Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome.

X. Mariette, P. Lagrange, F. Agbalika, 1993, Arthritis and rheumatism.

FEEDBACK INHIBITION OF SPECIFICALLY SENSITIZED LYMPHOCYTES

P. Lagrange, G. Mackaness, T. Miller, 1974, The Journal of experimental medicine.

FEEDBACK I NHIBITION OF SPECIFICALLY S ENSITIZED LYMPHOCYTES

P. Lagrange, G. Mackaness, T. E. Miller, 1974 .

Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus

P. Lagrange, F. Goldstein, J. Acar, 1978, Journal of clinical microbiology.

Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection.

P. Lagrange, J. Michel, B. Hurtrel, 1980, Annales d'immunologie.

IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigation.

R. Porcher, J. Herrmann, P. Lagrange, 2009, Pathologie-biologie.

Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria

P. Lagrange, B. Hurtrel, 1989 .

Induction of protective immunity to mycobacterial infections.

P. Lagrange, B. Hurtrel, 1986, Leprosy review.

Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains.

P. Lagrange, M. Gheorghiu, 1983, Annales d'immunologie.

Response to Dr Maes.

P. Lagrange, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Characterization of FOX-3, an AmpC-Type Plasmid-Mediated β-Lactamase from an Italian Isolate ofKlebsiella oxytoca

P. Lagrange, A. Marchese, A. Philippon, 1998, Antimicrobial Agents and Chemotherapy.

Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS.

P. Lagrange, J. Molina, F. Morinet, 1994, The American journal of medicine.

Immunopotentiation with BCG. I. Immune response to different strains and preparations.

P. Lagrange, G. Mackaness, D. Auclair, 1973, Journal of the National Cancer Institute.

The Cell Surface Receptor DC-SIGN Discriminates betweenMycobacterium Species through Selective Recognition of the Mannose Caps on Lipoarabinomannan*

B. Gicquel, O. Neyrolles, G. Puzo, 2003, The Journal of Biological Chemistry.

DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells

O. Schwartz, L. Tailleux, B. Gicquel, 2003, The Journal of experimental medicine.

A Novel Integron in Salmonella enterica Serovar Enteritidis, Carrying the blaDHA-1 Gene and Its Regulator Gene ampR, Originated fromMorganella morganii

G. Barnaud, P. Lagrange, A. Philippon, 2000, Antimicrobial Agents and Chemotherapy.

Paracoccidioidomycosis in silica-treated rats.

P. Lagrange, I. B. Kerr, S. C. D. da Costa, 1983, Immunology letters.

Absence of Correlation Between Delayed-Type Hypersensitivity and Protection in Experimental Systemic Candidiasis in Immunized Mice

P. Lagrange, J. Michel, B. Hurtrel, 1981, Infection and immunity.

Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages.

J. Herrmann, P. Lagrange, M. Fourgeaud, 1994, The Journal of antimicrobial chemotherapy.

Evaluation of Three Techniques for Detection of Low-Level Methicillin-Resistant Staphylococcus aureus (MRSA): a Disk Diffusion Method with Cefoxitin and Moxalactam, the Vitek 2 System, and the MRSA-Screen Latex Agglutination Test

P. Lagrange, I. Casin, Philippe Henri Lagrange, 2002, Journal of Clinical Microbiology.

Salmonella enteritidis: AmpC Plasmid-Mediated Inducible β-Lactamase (DHA-1) with anampR Gene from Morganella morganii

G. Barnaud, O. Gaillot, P. Lagrange, 1998, Antimicrobial Agents and Chemotherapy.

Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection

P. Lagrange, A. Hoffenbach, M. Bach, 1983, Infection and immunity.

Dissociation between cell-mediated immunity and acquired resistance in systemic murine candidiasis.

P. Lagrange, B. Hurtrel, 1985, Annales de l'Institut Pasteur. Immunologie.

Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate.

P. Lagrange, J. Michel, B. Hurtrel, 1980, Annales d'immunologie.

Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features.

R. Modigliani, F. Derouin, P. Lagrange, 1993, The Journal of infectious diseases.

Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2

P. H. Roy, P. Lagrange, A. Philippon, 1996, Antimicrobial agents and chemotherapy.

beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca

P. Lagrange, A. Philippon, B. Fournier, 1996, Antimicrobial agents and chemotherapy.

Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca

P. Lagrange, A. Philippon, R. Krishnamoorthy, 1995, Antimicrobial agents and chemotherapy.

Klebsiella oxytoca: Resistance to aztreonam by overproduction of the chromosomally encoded β‐lactamase

P. Lagrange, A. Philippon, G. Arlet, 1994 .

Anergy and Other Immunologic Perturbances in Mycobacterial Infections

P. Lagrange, B. Hurtrel, 1988 .

Campylobacter infections in HIV‐infected patients: clinical, and bacteriological features

P. Lagrange, I. Casin, J. Molina, 1995, AIDS.

Listeria monocytogenes infection in Biozzi mouse lines with high or low antibody responses, or with high (Hi/PHA) or low (Lo/PHA) responses to phytohemagglutinin.

P. Lagrange, B. Hurtrel, 1985, Cellular immunology.

A stable form of delayed-type hypersensitivity

P. Lagrange, G. Mackaness, 1975, The Journal of experimental medicine.

Effects of suramin on the immune responses to sheep red blood cells in mice. II. In vitro studies.

P. Lagrange, P. Truffa-bachi, I. Motta, 1985, Cellular immunology.

Risk factors for Clostridium difficile‐associated diarrhoea in HIV‐infected patients

Y. Hutin, P. Lagrange, I. Casin, 1993, AIDS.

Analysis of the immunological humoral response toMycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients

É. Oksenhendler, P. Lagrange, J. Molina, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis.

É. Oksenhendler, P. Lagrange, J. Molina, 1996, Clinical Microbiology and Infection.

Preliminary evaluation of a Mycobacterium tuberculosis lipooligosaccharide (LOS) antigen in the serological diagnosis of tuberculosis in HIV seropositive and seronegative patients.

P. Lagrange, G. Daleine, 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen.

J. Herrmann, P. Lagrange, C. Perronne, 2007, Tuberculosis.

THE MODIFYING EFFECT OF BCG ON THE IMMUNOLOGICAL INDUCTION OF T CELLS

P. Lagrange, G. Mackaness, T. Ishibashi, 1974, The Journal of experimental medicine.

Delayed-type hypersensitivity to rabies virus in mice: Immunosuppressive activity of salivary gland homogenate

P. Lagrange, J. Blancou, H. Tsiang, 1981 .

Vaccination of mice against Leishmania mexicana amazonensis with microsomal fraction associated with BCG.

P. Lagrange, S. C. Gonçalves da Costa, E. B. Santos, 1988, Annales de l'Institut Pasteur. Immunology.

Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships.

L. Abel, P. Lagrange, A. Alcaïs, 2000, The Journal of infectious diseases.

Experimental bases for the clinical use of immunostimulants

P. Lagrange, 1987 .

Mechanisms of T-cell unresponsiveness in leprosy.

P. Lagrange, D. Wallach, A. Hoffenbach, 1983, Annales d'immunologie.

Trypanosoma cruzi: histopathology of endocrine system in immunocompromised mice.

P. Lagrange, K. Calabrese, S. C. D. da Costa, 1994, International journal of experimental pathology.

Vaccines against mycobacteria and other intracellular multiplying bacteria.

P. Lagrange, B. Hurtrel, J. Stach, 1985, Annales de l'Institut Pasteur. Immunologie.

Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy.

J. Herrmann, P. Lagrange, A. Wargnier, 2000, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

In Vitro Effects of Sub-MIC’s of Antibiotics on the Antigenicity and Immunogenicity of Pseudomonas Aeruginosa

H. Richet, P. Lagrange, M. Escande, 1987 .

Immunological mechanisms controlling mycobacterial infections.

P. Lagrange, M. Brandely, B. Hurtrel, 1983, Bulletin europeen de physiopathologie respiratoire.

Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test

P. Lagrange, P. Ravisse, B. Hurtrel, 1978, Infection and immunity.

[Allergic granulomatous nodule of the conjunctiva disclosing onchocerciasis].

P. Lagrange, Y. Pouliquen, F. D'hermies, 1991, Journal francais d'ophtalmologie.

Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?

Delia Goletti, Camilla Rodrigues, Guy Vernet, 2010, PloS one.

Complex segregation analysis of leprosy in Southern Vietnam

L. Abel, P. Lagrange, E. Schurr, 1995, Genetic epidemiology.

Analysis of circulating immune complexes (CICs) in childhood tuberculosis: levels of specific antibodies to glycolipid antigens and relationship with serum antibodies.

P. Lagrange, A. Bourrillon, N. Simonney, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice.

P. Lagrange, H. Tsiang, 1980, The Journal of general virology.

Site of action of serum factors that block delayed-type hypersensitivity in mice

P. Lagrange, G. Mackaness, 1978, The Journal of experimental medicine.

Susceptibility to leprosy is linked to the human NRAMP1 gene.

L. Abel, P. Lagrange, E. Schurr, 1998, The Journal of infectious diseases.

In-vitro susceptibility of Klebsiella oxytoca strains to 13 β-lactams in the presence and absence of β-lactamase inhibitors

P. Lagrange, A. Philippon, B. Fournier, 1996 .

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

P. Lagrange, A. Philippon, G. Arlet, 2006, European Journal of Clinical Microbiology and Infectious Diseases.

Potency and suppurative adenitis in BCG vaccination.

P. Lagrange, L. Chambón, M. Gheorghiu, 1978, Developments in biological standardization.

Trypanosoma cruzi: infection patterns in intact and athymic mice of susceptible and resistant genotypes.

P. Lagrange, K. Calabrese, S. C. Gonçalves da Costa, 2002, Histology and histopathology.

Role of T lymphocytes in the resistance and immunopathology of experimental Chagas' disease. I. Histopathological studies.

P. Lagrange, B. Hurtrel, S. C. Gonçalves da Costa, 1984, Annales d'immunologie.

Immunomodulation with P40, an insoluble delipidated fraction of Corynebacterium granulosum. II.--Specific immune responses of the host.

P. Lagrange, M. J. Fuster, 1982, Annales d'immunologie.

Plasmid-Mediated Rifampin Resistance Encoded by anarr-2-Like Gene Cassette in Klebsiella pneumoniae Producing an ACC-1 Class C β-Lactamase

J. Herrmann, P. Lagrange, J. Donay, 2001, Antimicrobial Agents and Chemotherapy.

Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins

P. Lagrange, A. Philippon, G. Arlet, 1993, Antimicrobial Agents and Chemotherapy.

BCG: a modifier of immune responses to parasites.

P. Lagrange, D. Frommel, 1989, Parasitology today.

Trypanosoma cruzi invasion of structures related to development and central nervous system

P. Lagrange, K. Calabrese, S. C. Costa, 1986 .

Trypanosoma cruzi infection in immunosuppressed mice.

P. Lagrange, K. Calabrese, S. C. Gonçalves da Costa, 1992, Immunology letters.

Studies of the thymus in Chagas' disease: III. Colonization of the thymus and other lymphoid organs of adult and newborn mice by Trypanosoma cruzi.

P. Lagrange, K. Calabrese, W. Savino, 1991, Pathologie-biologie.

Escherichia hermannii: susceptibility pattern to β-lactams and production of β-lactamase

P. Grimont, P. Lagrange, A. Philippon, 1995 .

groups, blaOXY-1 and blaOXY-2. Klebsiella oxytoca are divided into two main Chromosomal beta-lactamase genes of

P. H. Roy, P. Lagrange, A. Philippon, 2013 .

Time course and histological differences between sheep red blood cells and tuberculin DTH reactions in mice.

P. Lagrange, M. Hurtrel, B. Hurtrel, 1984, Annales d'immunologie.

Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.

P. Lagrange, J. Michel, B. Hurtrel, 1980, Annales d'immunologie.

Physiopathologie des infections Salmonelles

P. Lagrange, J. Vildé, É. Koskas, 1978 .

Antitumor activity of two BCG vaccine preparations against the lewis lung carcinoma in mice

P. Lagrange, M. Gheorghiu, 1981, Cancer Immunology, Immunotherapy.

DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis

Jean-Louis Herrmann, Brigitte Gicquel, O. Schwartz, 2005, PLoS medicine.

Natural resistance to mycobacteria: antimicrobial activity and reactive oxygen intermediate releasing functions of murine macrophages.

P. Lagrange, M. Strobel, G. Delgado, 1984, Annales d'immunologie.

Chagas' disease: enhancement of systemic inflammatory reaction in cyclophosphamide treated mice.

P. Lagrange, K. Calabrese, K. Calabrese, 1996, International journal of immunopharmacology.

Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.

P. Lagrange, 1990, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice.

P. Lagrange, B. Hurtrel, 1979, Clinical and experimental immunology.

Lysis centrifugation and slide blood culture systems for diagnosis of bacteremia in immunocompromised patients

H. Richet, P. Lagrange, M. Escande, 1987, European Journal of Clinical Microbiology.

Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice

P. Lagrange, A. Hoffenbach, M. Bach, 1984, Infection and immunity.

Mycobacteriosis in the compromised host.

J. Herrmann, P. Lagrange, A. Wargnier, 2000, Memorias do Instituto Oswaldo Cruz.

Usefulness of serological tests in childhood TB

J. Herrmann, J. Herrmann, P. Lagrange, 2001 .

The immune responses in tuberculosis: Role for pathogenesis, diagnosis and prevention

J. Herrmann, P. Lagrange, A. Wargnier, 1999, Pediatric pulmonology. Supplement.

[Peptostreptococcus magnus osteoarticular infections after orthopedic surgery. 14 cases and pathogenicity factors].

L. Sedel, R. Nizard, P. Lagrange, 1998, Pathologie-biologie.

Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice.

P. Lagrange, M. Brandely, B. Hurtrel, 1986, Clinical and experimental immunology.

Enhanced resistance against lethal disseminated Candida albicans infection in mice treated with polar glycopeptidolipids from Mycobacterium chelonae (pGPL-Mc).

P. Lagrange, M. Fourgeaud, C. Pilet, 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Kinetics of different specific immunological parameters after rabies vaccination in mice

P. Lagrange, J. Blancou, H. Tsiang, 1979, Infection and immunity.

[Effects of intraperitoneal insufflation on hematogenous seeding of abdominal infections. Preliminary results of an experimental study in rats].

D. Gossot, S. Fritsch, Y. Révillon, 1995, Annales de chirurgie.

Molecular diagnosis of pulmonary tuberculosis by automated extraction and real-time PCR on non-decontaminated pulmonary specimens

J. Herrmann, P. Lagrange, V. Drouillon, 2007, European Journal of Clinical Microbiology and Infectious Diseases.

[Automated RNA amplification for the rapid identification of Mycobacterium tuberculosis complex in respiratory specimens].

J. Herrmann, P. Lagrange, V. Drouillon, 2006, Pathologie-biologie.

Diagnostic value of a nested polymerase chain reaction assay on peripheral blood mononuclear cells from patients with pulmonary and extra-pulmonary tuberculosis.

J. Herrmann, P. Lagrange, L. Hocqueloux, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Multicenter Evaluation of a Pathogenic Mycobacterium Screening Probe

K. Feldmann, J. Herrmann, P. Lagrange, 2001 .

Monitoring Treatment Efficacy

J. Herrmann, P. Lagrange, A. Wargnier, 2004 .

Antibody-based enzyme-linked immunosorbent assay for determination of anti-PGL-I specific circulating immune complex in leprosy patients.

P. Lagrange, P. Cruaud, J. Tomimori-Yamashita, 1999, Leprosy review.

Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.

P. Lagrange, C. Truffot-Pernot, J. Grosset, 1989, Clinical and experimental immunology.

Immunological behavior after mycobacterial infection in selected lines of mice with high or low antibody responses

P. Lagrange, B. Hurtrel, P. Thickstun, 1979, Infection and immunity.

Human immunodeficiency virus infection alters antigen-induced cytokine responses in patients with active mycobacterial diseases.

P. Lagrange, A. Nahmias, F. Lee, 1998, The Journal of infectious diseases.